繁體
简体中文
繁體中文

海恩時富 HAIN

等待開盤 07-18 09:30:00 美东时间

1.57

-0.020

-1.26%

华盛通華盛通
立即下載
  • 最 高1.62
  • 今 開1.60
  • 成交量 95.52万股
  • 最 低 1.56
  • 昨 收 1.59
  • 總市值 1.42亿
  • 52周最高 9.43
  • 市盈率 --
  • 換手率 1.06%
  • 52周最低 1.30
  • 委 比 65.19%
  • 總股本 9025.35万
  • 歷史最高 70.65
  • 量 比 0.70
  • 振 幅 3.77%
  • 歷史最低 1.30
  • 每 手 1
  • 風險率 2.53%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • The Herzfeld Caribbean Basin Fund, Inc. Pays Distribution

    The Herzfeld Caribbean Basin Fund (NASDAQ: CUBA) announced a distribution of $0.2325 per share under its Managed Distribution Policy. The distribution included approximately 80% in shares and 20% in cash, with a total of $731,093.39 distributed in cash and 1,187,755 shares issued. Stockholders who elected cash received $0.09418 per share, while those opting for shares received approximately 0.0944 shares. The Fund aims to provide a 15% annual dis...

    06-30 20:00

  • Food processors pressured by GIS results, Hawley lashes out at Tyson...again

    Weighed down by General Mills’ (GIS) soft organic sales and downbeat outlook, shares within the packaged food category are trading defensively on Wednesday, driving the Consumer Staples SPDR (XLP) low...

    06-26 00:48

  • 12 Consumer Staples Stocks Moving In Monday's After-Market Session

    Gainers Casey's General Stores (NASDAQ:CASY) shares moved upwards by 8.4% to $...

    06-10 05:05

  • 美股大行评级 | 潜在涨幅417.8%!RBC Capital上调Perspective Therapeutics目标价至16美元,维持"跑赢大市"评级

    <span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1136940401951563776.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• RBC Capital:维持Perspective Therapeutics(CATX)"跑赢大市"评级,目标价从15美元升至16美元</p> <p>• Canaccord Genuity:维持Taysha Gene Th

    06-04 08:35

  • 美股大行评级 | 英伟达、赛富时、C3.ai、Veeva Systems等获多家机构上调目标价!

    <span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1135136987677396993.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通:维持Cogent Biosciences(COGT)"超配"评级,目标价从21美元升至25美元</p> <p>• Chardan Capital:维持Taysha Gene Therapies(TSHA)"买入"

    05-30 09:09

  • 美股大行评级 | 拼多多遭多家大行下调评级!Redburn Atlantic首予博通"买入"评级

    <span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1134767544930545665.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim:维持AnaptysBio(ANAB)"买入"评级,目标价从54美元升至90美元</p> <p>• Canaccord Genuity:维持Bridger Aerospace Gr(BAER)"买入"评

    05-29 09:53

  • Deep Dive Into Hain Celestial Group Stock: Analyst Perspectives (8 Ratings)

    During the last three months, 8 analysts shared their evaluations of Hain Celes...

    05-29 06:00

  • Mizuho Maintains Neutral on Hain Celestial Group, Lowers Price Target to $3

    Mizuho analyst John Baumgartner maintains Hain Celestial Group (NASDAQ:HAIN) with a Neutral and lowers the price target from $3.5 to $3.

    05-29 01:51

  • The $600B Beverage Shift: Why Function Is Outpacing Flavor

    Equity Insider News Commentary Issued on behalf of Safety Shot, Inc. VANCOUVER, B.C., May 20, 2025 /PRNewswire/ -- Equity Insider News Commentary – In the U.S. and abroad, analysts report th...

    05-20 19:47

  • 美股大行评级 | 潜在涨幅455.56%!Medicus Pharma获D. Boral Capital升目标价至27美元,维持"买入"评级

    <span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1128971739548127232.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• D. Boral Capital:维持Medicus Pharma(MDCX)"买入"评级,目标价从14美元升至27美元</p> <p>• 蒙特利尔银行:维持Disc Medicine(IRON)"跑赢大市"评级,目标价从

    05-13 08:50